Do People with Parkinson’s Always Develop Dementia?

Translate to Spanish or other 102 languages!

For people with Parkinson’s disease, dementia develops less frequently and takes longer to develop than was previously believed, according to a new study analyzing two investigations of dementia and Parkinson’s. Image for illustration purposes
For people with Parkinson’s disease, dementia develops less frequently and takes longer to develop than was previously believed, according to a new study analyzing two investigations of dementia and Parkinson’s. Image for illustration purposes
- Advertisement -
  • Dementia for people with Parkinson’s disease may occur less often, and when it does occur, may develop later, a new study suggests.
  • Two new investigations have found that early understanding of dementia’s inevitability for Parkinson’s patients has been significantly overstated.
  • One of the new investigations found that less than 10% of people with the disease had developed dementia 10 years after diagnosis.

For people with Parkinson’s disease, dementia develops less frequently and takes longer to develop than was previously believed, according to a new study analyzing two investigations of dementia and Parkinson’s.

Follow the link below to Medical News Today of r the Full Story

https://www.medicalnewstoday.com/articles/parkinsons-disease-risk-developing-dementia-overstated

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

$281 Million Unlocked to Bridge the Gap in Rural Medical Access

AUSTIN - Governor Greg Abbott announced the Texas Health and Human Services Commission (HHSC) will receive $281 million in federal funding for the second year of Rural Texas Strong, a five-year initiative to improve rural healthcare throughout the state.

Skin Myths Dermatologists Want You to Stop Believing Immediately

Have you ever wondered what a dermatologist's top skincare recommendations are

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.
- Advertisement -